Clearance of prostaglandin F2ALPHA during circulatory shock.

The rate of disappearance of total circulating radioactivity following an intravenous bolus injection of 3HPGF_2α was determined during splanchnic artery occlusion (SAO) shock in the dog. In addition, the pattern of PGF_2α metabolite formation was assessed in both shocked and nonshocked animals. Although the clearance of circulating prostaglandin metabolites is significantly impaired during SAO shock as a result of decreased renal function, neither the pattern nor the time course of PGF_2α metabolite formation appears to be altered. Thus, increases in circulating prostaglandin concentrations during SAO shock reflect an increase in the rate of $\text{de novo}$ synthesis and release of these materials, and are not the result of decreased prostaglandin degradation.     

Intrauterine instillation of prostaglandin F2α in early pregnancy

Intrauterine PGF_2α (5mg) was administered for termination of early pregnancy in 14 healthy volunteers. With 11 complete abortions, the efficiency rate of this technique is below conventional methods. In addition, the incidence of infection was high occurring in 12 out of 14 subjects. Because of persistent bleeding, six patients underwent a dilatation and curettage. Other significant side effects included transient hypertension, pain, nausea and restlessness. In the patients with a complete abortion, the mean plasma progesterone concentration fell 37% after 8 hours post PGF_2α instillation and 90% 14 days later. The mean plasma estradiol-17β fell 26% over the initial eight hour period and 75% over the next 14 days.     

The excretion of prostaglandin F-2ALPHA in milk of cows.

Prostaglandin F-2ALPHA (PGF-2ALPHA) was measured by immunoassay in plasma and milk of four cows (six experiments). After 30 mg PGF-2ALPHA im, plasma PGF-2ALPHA peaked at 15 minutes (2.4 plus or minus 0.7 ng/ml) and declined toward basal values by 3 hours; maxiumum milk PGF-2ALPHA (0.91 plus or minus 0.12 ng/ml) occurred at 1 hour. The average excretion rate in milk was 2.9 mu-g/day 0.9 mu-g (0.003%) of which was due to the 30 mg PGF-2ALPHA injected. In six nonpregnant control cows, daily changes of milk PGF-2ALPHA and progesterone were not consistently related.     

激光照射胚泡对家兔和小鼠的抗早孕研究

本文在家兔、小鼠上探索了激光的抗旱孕效应,观察到血卟啉衍生物(HPD)和激光的光化效应能使早期胚泡完全坏死和吸收,无流血和晚期流产现象,通过PNQ_3荧光分光光度计测定HPD在胚胎组织中的荧光谱,证实HPD对胚胎组织有亲和力,其对滋养叶细胞比对宫壁组织的亲和力大4倍,借以解释激光光化效应抗早孕的可能机理。     

正常孕产妇血浆胃动素浓度变化

本文测定了１８０例正常孕产妇血浆胃动素浓度,并与２０例正常育龄妇女进行比较。结果表明：早期妊娠妇女血浆胃动素浓度（３８４．４０±１１０．３０ｎｇ／Ｌ）,比正常育龄妇女稍高（３６６．１２±９６．２３ｎｇ／Ｌ）Ｐ＞０．０５;中期妊娠者（３２３．９６±１２５．１０ｎｇ／Ｌ）比早孕者低Ｐ＜０．０５;晚期孕妇胃动素浓度（１２１．０４±２７．００ｎｇ／Ｌ）明显低于中孕者Ｐ＜０．０１;产妇血浆胃动素（４４３．０５±１４０．７９ｎｇ／Ｌ）迅速上升并高于正常育龄妇女Ｐ＜０．０５。为晚期妊娠者的３．１４倍Ｐ＜０．０１。结果提示妊娠影响了母体胃动素分泌和释放,妊娠时间越长,胃动素水平越低,妊娠终止后,胃动素水平明显升高。本文对妊娠及哺乳期妇女血浆胃动素浓度变化的机理及意义进行了讨论。     

Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung

Prostaglandin F synthetase from bovine lung was purified 540-fold to apparent homogeneity, as assessed by polyacrylamide gel electrophoreses and ultracentrifugation. The purified enzyme proved to be a monomeric protein with a molecular weight of about 30,500. The enzyme catalyzed not only the reduction of the 11-keto group of prostaglandin D2 but also the reduction of 9,11-endoperoxide of prostaglandin H2 and various carbonyl compounds (e.g. phenanthrenequinone). Experiments using column chromatography, polyacrylamide gel electrophoreses, immunotitration using antibody against the purified enzyme, and heat treatment indicated that three enzyme activities resided in a single protein. Although phenanthrenequinone and prostaglandin D2 competitively inhibited the prostaglandin D2 and phenanthrenequinone reductase activities, respectively, these two substrates were all but ineffective on the prostaglandin H2 (at the Km value) reductase activity up to 14-fold of those Km values. These results suggest that a single enzyme protein purified from the bovine lung catalyzes the reduction of prostaglandin D2, prostaglandin H2, and various carbonyl compounds and that prostaglandin D2 and prostaglandin H2 are metabolized at two different active sites, yielding prostaglandin F2 alpha as the reaction product.     

Histophysiological studies of prostaglandin F2alpha on isolated organs. I. Effect of prostaglandin F2alpha on the heart.

The physiological and histochemical effects of PGF2alpha on isolated rabbit hearts were examined. The results showed a positive inotropic effect. The coronary flow increased. From the histochemical studies, adenosine triphosphatase (ATP-ase) and succinic dehydrogenase activities were increased while that of alkaline phosphatase was decreased. Glycogen granules were depleted. These findings were discussed on a histophysiological basis.     

Role of prostaglandin F2alpha in ovulation.

Using radioimmunoassay procedures, the levels of plasma, uterine and ovarian prostaglandin (PG) F2alpha, and those of plasma estradiol and progesterone were measured in intact, hysterectomized or ovariectomized immature female rats pretreated with PMS and subsequent HCG. Occurrence of ovulation was confirmed at 8 hours after the HCG administration not only in the intact rats but also in the hysterectomzied rats. The levels of plasma estradiol and progesterone, and of uterine and ovarian PGF2alpha rose with the PMS injection alone, but they did not reach the peaks before the HCG administration. Both plasma estradiol and uterine PGF2alpha showed a peak at 2 hours after the HCG injection. These peaks were antecedent 2 or 6 hours before the peaks of ovarian and plasma PGF2alpha, respectively. However, such increase of uterine PGF2alpha does not seem to be indispensable for ovulation, because ovulation could occur in the hysterectomized rats. The levels of ovarian PGF2alpha showed a high plateau from 4 to 8 hours after the HCG injection, and then rapidly decreased after ovulation. The levels of plasma PGF2alpha peaked not only in the intact rats but also in the hysterectomized rats at 8 hours after the HCG treatment. But in the ovariectomized rats, this plasma PGF2alpha peak at 8 hours disappeared and there was no statistical change of plasma PGF2alpha throughout the PMS-HCG treatment. Plasma progesterone gradually increased and reached the maximum at 10 hours after the HCG injection. These results conclude that the main source of increased plasma PGF2alpha during the ovulatory process induced with the PMS-HCG treatment is the ovary, and it is strongly suggested that a rapid increase of PGF2alpha in the ovary may play some important role(s) in the ovulatory process.     

Intrauterine infusion of prostaglandin E2 and subsequent luteal function in cattle.

The objective was to evaluate the effect of intrauterine infusion of prostaglandin E2 (PGE2) on luteal function in cattle. Heifers and cows were randomly assigned after two normal estrous cycles to either PGE2 or control treatment groups. Females in Treatment A were infused with 1 mg of PGE2 once daily into the uterine horn ipsilateral to the corpus luteum between days 7-10 of the estrous cycle with a 0.25 ml plastic semen straw and an artificial insemination pipette. Females in Treatment B were similarly infused with 1 mg of PGE2 once daily in 20 ml of a carrier vehicle via a catheter on days 10 and 11 of the estrous cycle. Control animals were infused with the carrier vehicle using either a semen straw (Treatment C) or via a catheter (Treatment D) on the same days of the estrous cycle. Blood samples were collected daily to monitor plasma progesterone concentrations during the treatment period. Females infused with PGE2 on days 7-10 of the estrous cycle returned to estrus in a mean of 23.5 days (range 22-25 days) and were similar (P > 0.05) to those infused on days 10 and 11 which returned to estrus in 23.5 days (range 22-25 days). Animals similarly infused with carrier vehicle on the same days of the estrous cycle returned to standing estrus in 20.2 days (range 17-23 days). Plasma progesterone concentrations indicated an extended period of elevated progesterone concentrations in PGE2-treated animals compared with control animals. These results indicate that short term administration of PGE2 early in the estrous cycle may result in extended luteal maintenance.     

SENSITIVITY OF DAUDI CELLS TO TUMOR NECROSIS FACTOR ALPHA: EARLY CHANGES IN POLYPHOSPHOINOSITIDE METABOLISM

The effects of recombinant Tumor Necrosis Factor α (r-TNF α) on polyphosphoinositide metabolism were examined in a Burkitt Lymphoma cell line (Daudi cells). After 1h of in vitro treatment with r-TNF α, the incorporation of³²Pi into phosphatidylinositol 4,5-phosphate (PtdInsP₂), phosphatidylinositol 4-phosphate (PtdInsP) and phosphatidylinositol (PtdIns) was reduced compared with controls, confirming previous findings observed in other cell lines of a specific PtdIns breakdown following r-TNF α treatment. The novelty of this study is therefore the demonstration of early changes in polyphosphoinositide metabolism during the antiproliferative response elicited by this cytokine in Daudi cells.     

Assessment of possible luteolytic effect on intra-ovarian injection of prostaglandin F-2ALPHA in the human.

A group of five patients awaiting laparoscopic tubal diathermy were followed by daily assay of luteinising hormone (LH) and progesterone. Between five and eight days after the LH peak, prostaglandin F-2ALPHA (PGF-2ALPHA) was injected into either the corpus luteum or the ovarian stroma. Doses of 100 mu-g into the corpus tuteum, 1000 mu-g into the adjacent stroma and 500 mu-g into an indeterminate ovarian structure had no effect on peripheral plasma progesterone levels or uterine bleeding. An injection of 500 mu-g or 1000 mu-g given unequivocally into the corpus luteum produced a rapid and profound fall in plasma progesterone levels, the nadir coinciding with the onset of uterine bleeding which commenced 24 hours after the injection and persisted for more than seven days. Injection of 100 mu-g in the same volume of saline had no such effect. Despite continued bleeding plasma progesterone levels returned to normal luteal levels for three days and then fell again.     

大鼠动情周期及妊娠早期卵巢中明胶酶A活性变化

用酶谱法测定了大鼠动情周期以及正常妊娠早期和假孕早期不同时间卵巢中明胶酶Ａ活性的变化,并观察了甾体激素对明胶酶Ａ活性变化的影响,结果表明：在不同的周期及妊娠期卵巢中均存在６７ｋＤ为主的明胶酶Ａ,但未发现有明胶酶Ｂ存在。明胶酶Ａ活性变化如下：１）在大鼠的动情前期明胶酶Ａ的活性最高,间情期最低;２）在妊娠早期（１－７天）的卵巢中,明胶酶Ａ的活性在妊娠第４天达到最高,第１－３天及第５、６天其活性也较高,     

妊娠早期胎盘绒毛中肾素活性及其分泌的研究

取人工流产的不同妊娠周龄的人妊娠早期胎盘绒毛组织,测定其肾素活性及其在离体培养条件下肾素分泌,同时对组织中的血管紧张素Ⅰ和Ⅱ的含量进行测定。结果表明：人妊娠早期胎盘绒毛组织中的肾素活性较高,但随着妊娠周龄的增加,肾素活性明显降低。ＡⅡ含量随着妊娠周龄的增加而显著增加,与肾素活生的变化趋势相反;离体培养的绒毛有分泌肾素的能力,分泌能力随着妊娠周龄的增加而增加;在绒毛组织提取液和离体培养液中均未检测到     

Peroxisomal chain-shortening of prostaglandin F2 alpha

We have recently reported that prostaglandin F2 alpha can be chain-shortened by isolated rat liver peroxisomes. In the present study it is further established by cell fractionation experiments that the enzymes involved in this reaction are localized to peroxisomes. Under the conditions employed, the highest activity was found in the light mitochondrial fraction. Further fractionation of the light mitochondrial fraction by sucrose density gradient centrifugation showed that the prostaglandin oxidation activity comigrated with peroxisomal marker enzymes. Di(2-ethylhexyl)phthalate treatment resulted in a tenfold increased capacity for the conversion of prostaglandin F2 alpha into tetranorprostaglandin F1 alpha. The reaction was not inhibited by KCN. The reaction was further characterized with respect to cofactor requirements. The prostaglandin oxidation was found to be completely dependent on NAD, CoA, ATP, Mg2+ and was stimulated by FAD. Incubation of prostaglandin E2 with peroxisomes resulted in conversion into several products. After alkaline hydrolysis, one of these was identified as tetranorprostaglandin B1.